You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 10, October 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Short Course of Albendazole Therapy for Neurocysticercosis

Julio Sotelo, MD; Pedro Penagos, MD; Francisco Escobedo, MD; Oscar H. Del Brutto, MD

Arch Neurol. 1988;45(10):1130-1133.


Abstract

• Albendazole is now used for therapy of neurocysticercosis; however, duration of treatment has usually been empirically determined. In this study we shortened the length of therapy from one month in previous reports, to one week. Twelve patients with parenchymal brain cysticercosis were treated with albendazole for eight days at daily doses of 15 mg/kg of body weight. After three months of treatment the number of cysts on computed tomography had decreased from 185 to six; a 97% reduction in the number of lesions. Total remission of all cysts was seen in nine patients. Two cases had been unsuccessfully treated before with praziquantel, in both instances albendazole therapy was effective with 100% improvement. Our results indicated that a short course of albendazole is highly effective for treatment of neurocysticercosis.



Author Affiliations

From the Instituto Nacional de Neurologia y Neurocirugia, Mexico City.


Footnotes

Accepted for publication June 20, 1988.

Reprint requests to Research Division, Instituto Nacional de Neurologia y Neurocirugia, Insurgentes Sur 3877, 14410 Mexico 22, DF, Mexico (Dr Sotelo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of neurocysticercosis: current status and future research needs.
Nash et al.
Neurology 2006;67:1120-1127.
ABSTRACT | FULL TEXT  

Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel
Del Brutto et al.
ANN INTERN MED 2006;145:43-51.
ABSTRACT | FULL TEXT  

Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients
CARPIO; and DEL BRUTTO
J. Neurol. Neurosurg. Psychiatry 1999;66:411a-412.
FULL TEXT  

Medical Treatment of Cysticercosis--Effective
Del Brutto
Arch Neurol 1995;52:102-104.
ABSTRACT  

Albendazole Therapy for Giant Subarachnoid Cysticerci-Reply
Del Brutto
Arch Neurol 1993;50:348-348.
ABSTRACT  

Albendazole Therapy for Giant Subarachnoid Cysticerci
Brutto et al.
Arch Neurol 1992;49:535-538.
ABSTRACT  

Therapy for Neurocysticercosis: Comparison Between Albendazole and Praziquantel
Takayanagui and Jardim
Arch Neurol 1992;49:290-294.
ABSTRACT  

Albendazole Therapy for Neurocysticercosis
Del Brutto
Arch Neurol 1990;47:1278-1278.
ABSTRACT  

Albendazole Therapy for Neurocysticercosis-Reply
Alarcon
Arch Neurol 1990;47:1278-1279.
ABSTRACT  

Antihelminthic Therapy for Neurocysticercosis-Reply
Alarcon et al.
Arch Neurol 1990;47:1060-1060.
ABSTRACT  

Antihelminthic Therapy for Neurocysticercosis-Reply
Sotelo
Arch Neurol 1990;47:1059-1060.
ABSTRACT  

Neurocysticercosis as the Main Cause of Late-Onset Epilepsy in Mexico
Medina et al.
Arch Intern Med 1990;150:325-327.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.